XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Fair Value, by Balance Sheet Grouping

The following table shows the Company’s cash, cash equivalents and marketable debt securities by significant investment category as of December 31, 2024:

    

    

    

    

    

    

Current

    

Noncurrent

Amortized

Unrealized

Unrealized

Fair

Cash and Cash

Marketable

Marketable

Cost (1)

Gains

Losses

Value

Equivalents

Securities

Securities

Cash

    

$

    

$

    

$

    

$

    

$

3,020

    

$

    

$

Level 1:

  

  

  

  

  

  

  

Money market funds

 

 

 

 

 

94,112

 

 

U.S. Treasury securities

 

156,040

 

1,688

 

(6)

 

157,722

 

 

110,249

 

47,473

Subtotal

 

156,040

 

1,688

 

(6)

 

157,722

 

94,112

 

110,249

 

47,473

Level 2 (2):

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Commercial paper

 

19,902

 

531

 

 

20,433

 

 

20,433

 

Total

$

175,942

$

2,219

$

(6)

$

178,155

$

97,132

$

130,682

$

47,473

(1)There was no allowance for expected credit losses on available-for-sale debt securities as of December 31, 2024 as the unrealized losses were deemed to be temporary in nature.
(2)The valuation techniques used to measure the fair values of the Companys Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
Debt Securities, Available-for-Sale

The following table shows the fair value of the Company’s noncurrent marketable debt securities, by contractual maturity, as of December 31, 2024:

Due within 1 year

    

$

130,682

Due after 1 year through 5 years

 

47,473

Total fair value

$

178,155